An efficient early phase 2 procedure to screen medications for efficacy in smoking cessation

Sensitivity and specificity of a procedure for early human screening of novel smoking cessation medications

(2013) Kenneth A. Perkins et al.   ADDICTION

Biomarkers for Smoking Cessation

(2013) K J Bough et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

The First 7 Days of a Quit Attempt Predicts Relapse

(2013) Rebecca L. Ashare et al.   Journal of Addiction Medicine

Effect of Varenicline on Individual Nicotine Withdrawal Symptoms: A Combined Analysis of Eight Randomized, Placebo-Controlled Trials

(2013) J. Foulds et al.   NICOTINE & TOBACCO RESEARCH

Cigarette craving and withdrawal symptoms during temporary abstinence and the effect of nicotine gum

(2013) Jamie Brown et al.   PSYCHOPHARMACOLOGY

Comparisons of high-dose and combination nicotine replacement therapy, varenicline, and bupropion for smoking cessation: A systematic review and multiple treatment meta-analysis

(2012) Edward J. Mills et al.   ANNALS OF MEDICINE

Effects of 21 days of varenicline versus placebo on smoking behaviors and urges among non-treatment seeking smokers

(2012) Rebecca L Ashare et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Tobacco use in 3 billion individuals from 16 countries: an analysis of nationally representative cross-sectional household surveys

(2012) Gary A Giovino et al.   LANCET

Effectiveness of Coadministration of Varenicline, Bupropion, and Serotonin Reuptake Inhibitors in a Smoking Cessation Program in the Real-Life Setting

(2012) Jaqueline S. Issa et al.   NICOTINE & TOBACCO RESEARCH

Development of Novel Pharmacotherapeutics for Tobacco Dependence: Progress and Future Directions

(2012) D. Harmey et al.   NICOTINE & TOBACCO RESEARCH

Developing and Validating a Human Laboratory Model to Screen Medications for Smoking Cessation

(2012) S. A. McKee et al.   NICOTINE & TOBACCO RESEARCH

Smoking-Attributable Mortality by Cause in the United States: Revising the CDC's Data and Estimates

(2012) B. Rostron   NICOTINE & TOBACCO RESEARCH

Nicotine Therapy Sampling to Induce Quit Attempts Among Smokers Unmotivated to Quit

(2011) Matthew J. Carpenter   ARCHIVES OF INTERNAL MEDICINE

Early Human Screening of Medications to Treat Drug Addiction: Novel Paradigms and the Relevance of Pharmacogenetics

(2011) K A Perkins et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

The hardening hypothesis: Is the ability to quit decreasing due to increasing nicotine dependence? A review and commentary

(2011) John R. Hughes   DRUG AND ALCOHOL DEPENDENCE

Should All Smokers Use Combination Smoking Cessation Pharmacotherapy? Using Novel Analytic Methods to Detect Differential Treatment Effects Over 8 Weeks of Pharmacotherapy

(2011) W.-Y. Loh et al.   NICOTINE & TOBACCO RESEARCH

Treatment of nicotine addiction: present therapeutic options and pipeline developments

(2011) Riccardo Polosa et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Cross-Validation of a New Procedure for Early Screening of Smoking Cessation Medications in Humans

(2010) K A Perkins et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Application of Human Laboratory Models to Pharmacotherapy Development for Alcohol Dependence

(2010) Lara A. Ray et al.   CURRENT PHARMACEUTICAL DESIGN

Cochrane systematic reviews in the field of addiction: What's there and what should be

(2010) Laura Amato et al.   DRUG AND ALCOHOL DEPENDENCE

The relationship between in-treatment abstinence and post-treatment abstinence in a smoking cessation treatment.

(2010) Paul Romanowich et al.   EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY

Monetary incentives promote smoking abstinence in adults with attention deficit hyperactivity disorder (ADHD).

(2010) Scott H. Kollins et al.   EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY

Delay of smoking gratification as a laboratory model of relapse: effects of incentives for not smoking, and relationship with measures of executive function

(2009) Eldon T. Mueller et al.   BEHAVIOURAL PHARMACOLOGY

Prediction of abstinence at 10 weeks based on smoking status at 2 weeks during a quit attempt: Secondary analysis of two parallel, 10-week, randomized, double-blind, placebo-controlled clinical trials of 21-mg nicotine patch in adult smokers

(2009) Stuart G. Ferguson et al.   CLINICAL THERAPEUTICS

Development of pharmacotherapies for drug addiction: a Rosetta Stone approach

(2009) George F. Koob et al.   NATURE REVIEWS DRUG DISCOVERY

Severity of tobacco abstinence symptoms varies by time of day

(2009) Kenneth A. Perkins et al.   NICOTINE & TOBACCO RESEARCH

New horizons for therapeutics in drug and alcohol abuse

(2009) Bianca Jupp et al.   PHARMACOLOGY & THERAPEUTICS

The FDA Critical Path Initiative and Its Influence on New Drug Development

(2008) Janet Woodcock et al.   Annual Review of Medicine

The State of Innovation in Drug Development

(2008) I Kola   CLINICAL PHARMACOLOGY & THERAPEUTICS

Development of Procedures for Early Screening of Smoking Cessation Medications in Humans

(2008) KA Perkins et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

A placebo-controlled trial of modafinil for nicotine dependence

(2008) Robert A. Schnoll et al.   DRUG AND ALCOHOL DEPENDENCE

Challenges for translational psychopharmacology research—some basic principles

(2008) Klaus A. Miczek et al.   PSYCHOPHARMACOLOGY

Adjusted indirect comparison may be less biased than direct comparison for evaluating new pharmaceutical interventions

(2007) F. Song et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY